Literature DB >> 28987436

Ischemic Stroke: Advances in Diagnosis and Management.

Courtney R Cassella1, Andy Jagoda2.   

Abstract

Acute ischemic stroke carries the risk of morbidity and mortality. Since the advent of intravenous thrombolysis, there have been improvements in stroke care and functional outcomes. Studies of populations once excluded from thrombolysis have begun to elucidate candidates who might benefit and thus should be engaged in the process of shared decision-making. Imaging is evolving to better target the ischemic penumbra salvageable with prompt reperfusion. Availability and use of computed tomography angiography identifies large-vessel occlusions, and new-generation endovascular therapy devices are improving outcomes in these patients. With this progress in stroke treatment, risk stratification tools and shared decision-making are fundamental.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute ischemic stroke; Alteplase; Thrombectomy; Thrombolysis

Mesh:

Year:  2017        PMID: 28987436     DOI: 10.1016/j.emc.2017.07.007

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  13 in total

Review 1.  The Neuroprotective Roles of Sonic Hedgehog Signaling Pathway in Ischemic Stroke.

Authors:  Lian Liu; Bo Zhao; Xiaoxing Xiong; Zhongyuan Xia
Journal:  Neurochem Res       Date:  2018-09-28       Impact factor: 3.996

2.  Safranal protects against ischemia-induced PC12 cell injury through inhibiting oxidative stress and apoptosis.

Authors:  Fatemeh Forouzanfar; Elham Asadpour; Hossein Hosseinzadeh; Mohammad Taher Boroushaki; Afrouz Adab; Seyedeh Hoda Dastpeiman; Hamid R Sadeghnia
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-31       Impact factor: 3.000

3.  Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats.

Authors:  Gang Zuo; Dongping Zhang; Rutao Mu; Haitao Shen; Xiang Li; Zhong Wang; Haiying Li; Gang Chen
Journal:  Mol Brain       Date:  2018-02-13       Impact factor: 4.041

Review 4.  Cytochrome P450 family 4 subfamily F member 2 (CYP4F2) rs1558139, rs2108622 polymorphisms and susceptibility to several cardiovascular and cerebrovascular diseases.

Authors:  Tao Zhang; Kuiying Yu; Xuhua Li
Journal:  BMC Cardiovasc Disord       Date:  2018-02-09       Impact factor: 2.298

Review 5.  Role of Resolvins in the Inflammatory Resolution of Neurological Diseases.

Authors:  Chunrong Li; Xiujuan Wu; Shan Liu; Donghui Shen; Jie Zhu; Kangding Liu
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

Review 6.  Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.

Authors:  Marzena Ułamek-Kozioł; Stanisław Jerzy Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

Review 7.  Effects of Thrombin on the Neurovascular Unit in Cerebral Ischemia.

Authors:  Hui Cao; Sai Wang Seto; Deep Jyoti Bhuyan; Hoi Huen Chan; Wenting Song
Journal:  Cell Mol Neurobiol       Date:  2021-01-03       Impact factor: 5.046

8.  Heterogeneity in brain distribution of activated microglia and astrocytes in a rat ischemic model of Alzheimer's disease after 2 years of survival.

Authors:  Lidija Radenovic; Marija Nenadic; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar; Pavle R Andjus; Ryszard Pluta
Journal:  Aging (Albany NY)       Date:  2020-06-05       Impact factor: 5.955

Review 9.  Tau Protein Dysfunction after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 10.  Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.

Authors:  Marzena Ułamek-Kozioł; Stanisław J Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.